載入...
CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
The interleukin-3 receptor alpha chain (IL-3Rα), more commonly referred to as CD123, is widely overexpressed in various hematological malignancies, including acute myeloid leukemia (AML), B-cell acute lymphoblastic leukemia, hairy cell leukemia, Hodgkin lymphoma and particularly, blastic plasmacytoi...
Na minha lista:
| 發表在: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769702/ https://ncbi.nlm.nih.gov/pubmed/31547472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11091358 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|